Clinical trial
The Role of Matrix Metalloproteinases on the Primary Teeth Pulpotomy Treatments With MTA and Biodentine
NCT05145686 is registered in ClinicalTrials.gov with Ege University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of Matrix Metalloproteinases on the Primary Teeth Pulpotomy Treatments With MTA and Biodentine
- Lead sponsor
- Ege University
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- January 1, 2018
- Completion date
- December 1, 2019
- Enrollment
- 57 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
reversible pulpitis